Fellowship · Salt Lake City, UT
Sponsored by University of Utah Health
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Hepatology (Baltimore, Md.) · 2023 · 350 citations · Mark Deneau
Telemedicine in Low- and Middle-Income Countries During the COVID-19 Pandemic: A Scoping Review.
Frontiers in public health · 2022 · 95 citations · Catalina Jaramillo
Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort.
Hepatology (Baltimore, Md.) · 2024 · 34 citations · Stephen Guthery
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
Alimentary pharmacology & therapeutics · 2024 · 37 citations · Stephen Guthery, Trevor Laborda, Mark Deneau
Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy.
Hepatology (Baltimore, Md.) · 2023 · 39 citations · Stephen Guthery
Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients.
JAMA network open · 2023 · 42 citations · Catalina Jaramillo
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.
Hepatology (Baltimore, Md.) · 2024 · 27 citations · Catalina Jaramillo
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation.
Journal of hepatology · 2022 · 54 citations · Mark Deneau